Hildred Capital Management will acquire Hello Bello, according to a news release.
Hello Bello, founded in 2019 and based in Pacific Palisades, Calif., produces baby and family care products.
Hildred, based in New York, is healthcare-focused private equity firm. Founded in 2018, the firm pursues growth equity investments and seeks to invest
OrbiMed has announced it has raised more than $4.3 billion in commitments for its latest private investment funds.
These new funds include OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit Opportunities IV.
OrbiMed, headquartered in New York, is a life sciences investment firm with more than $17 billion in
On Oct. 13, the U.S. Department of Health and Human Services Office of Inspector General issued an advisory opinion approving a physician practice’s proposal to pay bonuses to each of its employed physicians based on net profits derived from the facility fee generated by procedures the physician performed at the practice’s ambulatory surgery center.
COMPLIMENTARY WEBINARTuesday, November 2, 202312-1 p.m. (ET) | 11 a.m.-12 p.m. (CT) | 9-10 a.m. (PT)
Join McGuireWoods partners Kayla McCann Marty and Gretchen Townshend for an informative webinar on the latest developments impacting hospitals, health systems and outpatient facilities. They will explore:
Summit Partners has invested in Hallmark Health Care Solutions, according to a news release.
Hallmark, based in Hauppauge, N.Y., is a healthcare consulting and technology firm. The software-as-a-service (SaaS) company offers physician compensation and workforce management solutions for health systems, academic medical centers and physician groups.
Summit, based in Boston, pursues opportunities
On 26 October 2023, the Economic Crime and Corporate Transparency Act received royal assent. The new law is designed to fight corruption, money laundering and fraud, and has major implications for businesses, including:
On this episode of The Professor’s Corner, Diwakar Sinha of Polaris Healthcare Partners joins McGuireWoods’ Geoff Cockrell to discuss how practices can prepare to sell, what specialties are most attractive and how the search for investors varies from practice to practice.
According to Diwakar, the same volume of deals is occurring, but the number
The U.S. Department of Health and Human Services (HHS) Office of Research Integrity (ORI) released a notice of proposed rulemaking to update the 2005 Public Health Service (PHS) Policies on Research Misconduct. HHS seeks public comments on the proposal through Dec. 5, 2023.
ORI expects the proposed changes to be effective Jan. 1, 2025. If
September was an active month for Ponzi litigation with nearly a dozen new complaints filed alleging fraudulent investment activity. The SEC continues to drive Ponzi-related litigation; in addition to four enforcement actions brought last month, previous SEC litigation precipitated several complaints filed by investors and court-appointed receivers. Consistent with the trends discussed in Ponzi Perspective’s Midyear Roundup, the majority of actions filed in September involved real estate investment schemes and targeted solicitation of affinity groups.
Notable litigation filed in September 2023 includes: (1) Conlan v. Roach, et al.; (2) Reispec Develop. LLC v. Pina, et al.; (3) Dottore v. SDR Realty; (4) SEC v. Kubler, et al.; (5) McGrath v. Palowet Inv., LLC; (6) SEC v. Feloni, et al.; (7) SEC v. Aras Inv. Bus. Grp., et al.; (8) American Eagle Oil & Gas Co., et al. v. Navarro Prod. Co., et al.; (9) Luppino v. Spano, et al.; and (10) SEC v. Motil, et al.
McGuireWoods recently held its 16th annual Healthcare Finance & Growth Conference, during which speakers and industry leaders examined various subtopics in the healthcare space.
During the conference, Jeremy Johnson, Senior Managing Director, Head of Investment Banking at Bourne Partners, and Jeff Edwards, a partner at QHP Capital, participated in an afternoon panel discussion of current